Literature DB >> 3376977

Acyclovir-induced renal failure. Clinical course and histology.

M H Sawyer1, D E Webb, J E Balow, S E Straus.   

Abstract

Four patients with a chronic fatigue syndrome experienced five episodes of acute renal insufficiency associated with high-dose (500 mg/m2) intravenous acyclovir administered intravenously as one-hour infusions. Nephrotoxicity developed despite precautions to avoid volume contraction. Examination of the urinary sediment of three patients by polarizing microscopy showed birefringent needle-shaped crystals within leukocytes. In the most severely affected patient, a serum creatinine concentration of 8.6 mg/dl developed and the patient underwent percutaneous renal biopsy that revealed foci of interstitial inflammation without tubular necrosis. Urine, blood, and renal tissue levels of acyclovir were high. One patient was rechallenged with low-dose intravenous acyclovir and the four patients later received oral acyclovir, all without adverse effect. The combined data from these patients support crystalluria and obstructive nephropathy as a mechanism of acyclovir-induced renal failure in humans. This experience emphasizes the importance of maintaining adequate hydration during high-dose acyclovir therapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3376977     DOI: 10.1016/0002-9343(88)90313-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  46 in total

1.  Acyclovir-induced renal failure: course and risk factors.

Authors:  M G Bianchetti; C Roduit; O H Oetliker
Journal:  Pediatr Nephrol       Date:  1991-03       Impact factor: 3.714

2.  Pharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipients.

Authors:  C V Fletcher; J A Englund; C K Edelman; C R Gross; D L Dunn; H H Balfour
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

Review 3.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

Review 4.  Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management.

Authors:  Michael J Bradshaw; Arun Venkatesan
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

5.  Acute kidney injury due to acyclovir.

Authors:  Cigdem Yildiz; Yasemin Ozsurekci; Safak Gucer; Ali Bulent Cengiz; Rezan Topaloglu
Journal:  CEN Case Rep       Date:  2012-10-01

6.  An extract of Stephania hernandifolia, an ethnomedicinal plant, inhibits herpes simplex virus 1 entry.

Authors:  Joy Mondal; Ananya Das Mahapatra; Keshab C Mandal; Debprasad Chattopadhyay
Journal:  Arch Virol       Date:  2021-05-26       Impact factor: 2.574

Review 7.  Renal disease in patients with HIV infection: epidemiology, pathogenesis and management.

Authors:  Derek M Fine; Mark A Perazella; Gregory M Lucas; Mohamed G Atta
Journal:  Drugs       Date:  2008       Impact factor: 9.546

8.  Nephrotoxicity of acyclovir and cis-diamminedichloroplatinum(II)--effect of co-administration in rats.

Authors:  J Hannemann; W Wunderle; K Baumann
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

9.  Determinants of aciclovir-induced nephrotoxicity in children.

Authors:  Ruth Schreiber; Jacob Wolpin; Gideon Koren
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

10.  Antiviral selection in the management of acute retinal necrosis.

Authors:  Patrick M K Tam; Claire Y Hooper; Susan Lightman
Journal:  Clin Ophthalmol       Date:  2010-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.